Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Primary Dysautonomias 1Polycystic Ovary Syndrome 1Metabolic Syndrome 1Insulin Resistance 1Hyperandrogenism 1

Interventions

Metformin 149Clomiphene 51Letrozole 39Inositol 35Folic Acid 18Exercise 17Progesterone 15Ethinyl Estradiol 13Chorionic Gonadotropin 13Caloric Restriction 13drospirenone and ethinyl estradiol combination 12Estradiol 12Contraceptives, Oral 11cetrorelix 10Pioglitazone 10High-Intensity Interval Training 10Tablets 9Spironolactone 9Cholecalciferol 9Triptorelin Pamoate 8Diet 8Vitamin D 7Thioctic Acid 7Menotropins 7Liraglutide 7Acupuncture Therapy 7drospirenone 6Ovidrel 6Gonadotropins 6Flutamide 6

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Polycystic Ovary Syndrome × Bloodletting × Clear all
NCT02460445 2022-07-27

Phlebotomy and Polycystic Ovary Syndrome

Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal

Phase NA Completed
37 enrolled

Insulin Resistance, Polycystic Ovary Syndrome, Hyperandrogenism, Metabolic Syndrome, Primary Dysautonomias

Data powered by HemOnc (CC BY 4.0) Colophon âš¡